(Q39556429)

13 September 2017

The physiological role of endogenous endothelin in the regulation of human coronary vasomotor tone (English)

1 reference

13 September 2017

4

1 reference

13 September 2017

MacCarthy PA

1

1 reference

13 September 2017

Pegge NC

series ordinal

2

1 reference

13 September 2017

Prendergast BD

series ordinal

3

1 reference

13 September 2017

Groves PH

series ordinal

5

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Journal of the American College of Cardiology

13 September 2017

1 reference

13 September 2017

37

1 reference

13 September 2017

1

1 reference

13 September 2017

137-143

1 reference

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

The endothelin system and its potential as a therapeutic target in cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Contribution of endogenous generation of endothelin-1 to basal vascular tone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Endothelin. Key to coronary vasospasm?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Endothelin in Coronary Endothelial Dysfunction and Early Atherosclerosis in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Endothelin Peptide and Receptors in Human Atherosclerotic Coronary Artery and Aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Role of endogenous bradykinin in human coronary vasomotor control

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Impaired coronary dilator responses to substance P and impaired flow-dependent dilator responses in heart transplant patients with graft vasculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Substance P dilates epicardial coronary arteries and increases coronary blood flow in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Endothelin receptors in the failing and nonfailing human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Flow-dependent coronary artery dilatation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Endothelin as a regulator of cardiovascular function in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Evidence for heterogeneity of endothelin receptor distribution in human coronary artery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Endothelin-induced endocytosis of cell surface ETA receptors. Endothelin remains intact and bound to the ETA receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Endothelins come of age

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Myocardial endothelin. Does it play a role in myocardial failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Endothelin is a potent mitogen for rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Selective ET(A) receptor antagonism reduces neointimal hyperplasia in a porcine coronary stent model

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Short-term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901042-1

7 January 2021

10.1016/S0735-1097(00)01042-1

Identifiers

DOI

1 reference

13 September 2017

1 reference